| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.3M | +30.0% |
| Cost of Revenue | $2.1M | -35.1% |
| Gross Profit | $9.2M | +68.5% |
| R&D Expense | $1.8M | -47.9% |
| SG&A Expense | $5.1M | -25.4% |
| Operating Income | $3.2M | +285.7% |
| Interest Expense | $19K | -84.4% |
| Pre-tax Income | $6.6M | +316.5% |
| Income Tax | -$245K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.0M | +481.1% |
| Current Assets | $7.6M | +171.3% |
| Total Assets | $12.0M | +90.9% |
| Current Liabilities | $3.4M | -33.0% |
| Total Liabilities | $4.4M | -13.0% |
| Stockholders' Equity | $6.8M | +1265.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.1M | +243.5% |
| Capital Expenditures | $12K | -51.8% |
| Investing Cash Flow | -$1.1M | -195.0% |
| Financing Cash Flow | $1.1M | +27.5% |
| Free Cash Flow | $4.1M | +241.8% |
| — |
| Net Income | $6.9M | +351.7% |
| EPS (Basic) | $1.43 | +252.1% |
| EPS (Diluted) | $1.43 | +252.1% |